Amifostine Hydrate
目录号: A14238
Amifostine 是第一个获批的放射防护药物,用于降低顺铂治疗引起的肾脏问题的风险。
Discription | Amifostine is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin. |
---|
目录号 | A14238 |
---|---|
分子式 | C5H15N2O3PS.3H2O |
分子量 | 268.27 |
CAS号 | 112901-68-5 |
SMILES | C(CN)CNCCSP(=O)(O)O.O.O.O |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | Insoluble | |
Water | Warmed: 39 mg/mL (145.37 mM) | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 37.28 mL | 186.38 mL | 372.76 mL |
0.5 mM | 7.46 mL | 37.28 mL | 74.55 mL |
1 mM | 3.73 mL | 18.64 mL | 37.28 mL |
5 mM | 0.75 mL | 3.73 mL | 7.46 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2